piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation

Cellular Signalling · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles